Certain Investors Seek Injunction against Sale of Beckman Coulter

Feb 10, 2011

NEW YORK (GenomeWeb News) – Plaintiffs have filed an amendment to their lawsuit against Beckman Coulter seeking to stop the diagnostic firm's board of directors from selling the company to Danaher.

The class action lawsuit is currently pending in the Superior Court of the State of California, County of Orange, and consolidates a number of cases against Beckman Coulter, its board, and certain officers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Second One From Kite

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Worth the Price?

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Beyond Counting Tree Rings

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

This Week in Nature

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.

Main menu